M E Molitch

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. ncbi request reprint Pharmacologic resistance in prolactinoma patients
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 303 E Chicago Avenue, Tarry 15 731, Chicago, IL 60611, USA
    Pituitary 8:43-52. 2005
  2. ncbi request reprint Prolactin excess: treatment and toxicity
    Mary P Gillam
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA, and Endocrinology Unit, Alvarez Hospital, Buenos Aires, Argentina
    Pediatr Endocrinol Rev 2:108-14. 2004
  3. doi request reprint Growth hormone treatment in adults with growth hormone deficiency: the transition
    M E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine Chicago, 645 N Michigan Avenue, Suite 530 Chicago, IL 60611, USA
    J Endocrinol Invest 34:150-4. 2011
  4. ncbi request reprint Current state of type 2 diabetes management
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Am J Manag Care 19:S136-42. 2013
  5. doi request reprint Current approaches to the pharmacological management of Cushing's disease
    Mark E Molitch
    Martha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Electronic address
    Mol Cell Endocrinol 408:185-9. 2015
  6. doi request reprint Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma
    Mark E Molitch
    Division of EndocrinologyMetabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 North Michigan Avenue, Suite 530, Chicago, Illinois 60611, USA
    Eur J Endocrinol 172:R205-13. 2015
  7. doi request reprint Nonfunctioning pituitary tumors
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Electronic address
    Handb Clin Neurol 124:167-84. 2014
  8. pmc Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology
    Patrice Lazure
    AXDEV Group Inc, 210 8, Place du Commerce, Brossard, QC J4W 3H2, Canada
    BMC Health Serv Res 14:319. 2014
  9. doi request reprint Management of medically refractory prolactinoma
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 530, Chicago, IL, 60611, USA
    J Neurooncol 117:421-8. 2014
  10. doi request reprint Tumors invading the cavernous sinus that cause internal carotid artery compression are rarely pituitary adenomas
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 530, Chicago, IL 60611, USA
    Pituitary 15:598-600. 2012

Detail Information

Publications54

  1. ncbi request reprint Pharmacologic resistance in prolactinoma patients
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 303 E Chicago Avenue, Tarry 15 731, Chicago, IL 60611, USA
    Pituitary 8:43-52. 2005
    ..Reduction of endogenous estrogen, use of selective estrogen receptor modulators, and aromatase inhibitors are potential experimental approaches...
  2. ncbi request reprint Prolactin excess: treatment and toxicity
    Mary P Gillam
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA, and Endocrinology Unit, Alvarez Hospital, Buenos Aires, Argentina
    Pediatr Endocrinol Rev 2:108-14. 2004
    ..When fertility is desired, bromocriptine is generally preferable, but cabergoline is also likely safe; pergolide and quinagolide should not be used in this setting...
  3. doi request reprint Growth hormone treatment in adults with growth hormone deficiency: the transition
    M E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine Chicago, 645 N Michigan Avenue, Suite 530 Chicago, IL 60611, USA
    J Endocrinol Invest 34:150-4. 2011
    ..It is important for pediatric endocrinologists to discuss the potential need for continued treatment beyond achievement of adult height at the time of initiation of GH treatment, especially in those children with organic causes of GHD...
  4. ncbi request reprint Current state of type 2 diabetes management
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Am J Manag Care 19:S136-42. 2013
    ..Recognition of the various factors influencing therapeutic choices is also critical for improved patient management. ..
  5. doi request reprint Current approaches to the pharmacological management of Cushing's disease
    Mark E Molitch
    Martha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Electronic address
    Mol Cell Endocrinol 408:185-9. 2015
    ..Combinations of drugs can be tried in patients resistant to monotherapy. ..
  6. doi request reprint Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma
    Mark E Molitch
    Division of EndocrinologyMetabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 North Michigan Avenue, Suite 530, Chicago, Illinois 60611, USA
    Eur J Endocrinol 172:R205-13. 2015
    ..Delivery of the baby and placenta can also be considered if the pregnancy is sufficiently advanced. Transsphenoidal debulking of the tumor is rarely necessary. ..
  7. doi request reprint Nonfunctioning pituitary tumors
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Electronic address
    Handb Clin Neurol 124:167-84. 2014
    ..For those with visible tumor, the tumor regrowth rate is about 40%. This regrowth rate may be substantially reduced with the use of dopamine agonists and radiotherapy. ..
  8. pmc Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology
    Patrice Lazure
    AXDEV Group Inc, 210 8, Place du Commerce, Brossard, QC J4W 3H2, Canada
    BMC Health Serv Res 14:319. 2014
    ....
  9. doi request reprint Management of medically refractory prolactinoma
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 530, Chicago, IL, 60611, USA
    J Neurooncol 117:421-8. 2014
    ..Temozolomide may be useful as a last resort for aggressive, invasive tumors refractory to other medical and ablative therapies...
  10. doi request reprint Tumors invading the cavernous sinus that cause internal carotid artery compression are rarely pituitary adenomas
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 530, Chicago, IL 60611, USA
    Pituitary 15:598-600. 2012
    ..0007). A mass lesion that invades the cavernous sinus and encases the internal carotid artery is very unlikely, therefore, to be a pituitary adenoma if it compresses the lumen of the internal carotid artery...
  11. doi request reprint Management of incidentally found nonfunctional pituitary tumors
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Neurosurg Clin N Am 23:543-53. 2012
    ..Potential indications for surgery are growth of a pituitary incidentaloma, the development of visual-field defects, or the development of hypopituitarism...
  12. doi request reprint Prolactinoma in pregnancy
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Best Pract Res Clin Endocrinol Metab 25:885-96. 2011
    ....
  13. pmc The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome
    Anne Klibanski
    Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
    Pituitary 13:266-86. 2010
    ..Panel opinions, based on the level of available scientific evidence, were polled. Finally, their views were compared with those of surveyed community-based endocrinologists and neurosurgeons...
  14. doi request reprint Pituitary tumours: pituitary incidentalomas
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 530, Chicago, IL 60611, USA
    Best Pract Res Clin Endocrinol Metab 23:667-75. 2009
    ..In the absence of hypersecretion, hypopituitarism or visual field defects, patients may be followed up by periodic screening by MRI for enlargement. Growth of a pituitary incidentaloma is an indication for surgery...
  15. ncbi request reprint Medical management of prolactin-secreting pituitary adenomas
    Mark E Molitch
    Center for Endocrinology, Metabolism and Molecular Medicine, North Western University, The Feinberg Medical School, Chicago, IL 60611, USA
    Pituitary 5:55-65. 2002
    ..However, for other indications, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective...
  16. ncbi request reprint Management of dyslipidemias in patients with diabetes and chronic kidney disease
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 303 E Chicago Avenue Tarry 15 731, Chicago, IL 60611, USA
    Clin J Am Soc Nephrol 1:1090-9. 2006
    ..Overall, on the basis of the very high risk for CVD in patients with diabetes and CKD, aggressive management of dyslipidemias is warranted, with an LDL goal of 70 mg/dl...
  17. doi request reprint Drugs and prolactin
    Mark E Molitch
    Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Pituitary 11:209-18. 2008
    ..If the hyperprolactinemia is symptomatic, management strategies include switching to an alternative medication which does not cause hyperprolactinemia, using estrogen/testosterone replacement, or cautiously adding a dopamine agonist...
  18. ncbi request reprint Lanreotide Autogel in the management of acromegaly
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Drugs 68:724. 2008
  19. doi request reprint Nonfunctioning pituitary tumors and pituitary incidentalomas
    Mark E Molitch
    Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 North Michigan Avenue, Suite 530, Chicago, IL 60611, USA
    Endocrinol Metab Clin North Am 37:151-71, xi. 2008
    ..The regrowth rate may be substantially reduced with the use of dopamine agonists and radiotherapy...
  20. ncbi request reprint Prolactin-secreting tumors: what's new?
    Mark E Molitch
    Northwestern University Feinberg School of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, 303 E Chicago Avenue, Chicago, IL, USA
    Expert Rev Anticancer Ther 6:S29-35. 2006
    ..However, for other indications, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective or not tolerated...
  21. ncbi request reprint Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave Tarry 15 731, Chicago, Illinois 60611, USA
    Diabetes Care 29:78-82. 2006
    ..The objective of this study was to determine whether high levels of HDL cholesterol are associated with a lower prevalence of albuminuria..
  22. ncbi request reprint Pituitary disorders during pregnancy
    Mark E Molitch
    Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 15 731, Chicago, IL 60611, USA
    Endocrinol Metab Clin North Am 35:99-116, vi. 2006
  23. ncbi request reprint Medication-induced hyperprolactinemia
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Mayo Clin Proc 80:1050-7. 2005
    ....
  24. ncbi request reprint The pituitary mass: diagnosis and management
    Susan Sam
    Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine
    Rev Endocr Metab Disord 6:55-62. 2005
  25. ncbi request reprint Dopamine resistance of prolactinomas
    Mark E Molitch
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Pituitary 6:19-27. 2003
    ..Reduction of endogenous estrogen, use of selective estrogen receptor modulators, and aromatase inhibitors are potential experimental approaches...
  26. ncbi request reprint Pituitary tumors and pregnancy
    Mark E Molitch
    Center for Endocrinology, Metabolism and Molecular Medicine, The Feinberg Medical School, Northwestern University, Chicago, IL, USA
    Growth Horm IGF Res 13:S38-44. 2003
    ..An increase in the size of other types of tumors during pregnancy is very rare...
  27. ncbi request reprint Disorders of prolactin secretion
    M E Molitch
    Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois, USA
    Endocrinol Metab Clin North Am 30:585-610. 2001
    ..For other indications, cabergoline seems to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective...
  28. doi request reprint Lymphocytic hypophysitis
    Mark E Molitch
    Division of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill 60611, USA
    Horm Res 68:145-50. 2007
    ..Lymphocytic hypophysitis is a disorder of the pituitary gland that presents as a sellar mass lesion and/or hypopituitarism. It causes pituicyte destruction and hypopituitarism and is speculated to have an autoimmune basis...
  29. ncbi request reprint Medical treatment of prolactinomas
    M E Molitch
    Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois, USA
    Endocrinol Metab Clin North Am 28:143-69, vii. 1999
    ..For other indications, however, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective...
  30. ncbi request reprint The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma
    Mary P Gillam
    Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University, The Feinberg Medical School, Chicago, Illinois 60611, USA
    J Clin Endocrinol Metab 87:4447-51. 2002
    ..Ultimately, further reduction in PRL on this therapy permitted endogenous testosterone production. Thus, novel pharmacological maneuvers may permit successful medical treatment of some patients with invasive macroprolactinomas...
  31. ncbi request reprint Prolactin and autoimmune diseases in humans
    Ellie Chuang
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Acta Biomed 78:255-61. 2007
    ....
  32. ncbi request reprint Timing and special concerns regarding endocrine surgery during pregnancy
    Susan Sam
    Division of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611, USA
    Endocrinol Metab Clin North Am 32:337-54. 2003
    ..The best outcome is achieved by a multidisciplinary approach consisting of endocrinology, obstetrics, anesthesiology, and endocrine surgery...
  33. pmc Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study
    Mark E Molitch
    Northwestern University, Chicago, Illinois, USA
    Diabetes Care 33:1536-43. 2010
    ..73 m(2) in type 1 diabetes up to year 14 of the Epidemiology of Diabetes Interventions and Complications (EDIC) study (mean duration of 19 years in the Diabetes Control and Complications Trial [DCCT]/EDIC)...
  34. ncbi request reprint Advances in the treatment of prolactinomas
    Mary P Gillam
    Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Endocr Rev 27:485-534. 2006
    ....
  35. doi request reprint Diabetes, cardiovascular risk and nephropathy
    Allison J Hahr
    Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Cardiol Clin 28:467-75. 2010
    ..Reduction of other risk factors, such as smoking cessation and weight reduction, should also be implemented. Multiple risk factor reduction can have a large effect on reduction of CVD outcomes...
  36. ncbi request reprint Screening for kidney disease in adults with diabetes
    Holly Kramer
    Department of Preventive Medicine, Division of Nephrology, Loyola University Medical Center, Maywood, IL, USA
    Diabetes Care 28:1813-6. 2005
  37. pmc Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
    Roberto Salvatori
    Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Pituitary 13:115-22. 2010
    ..0001). Self- or partner-administration of lanreotide is generally well tolerated and associated with IGF-1 and GH control in many lanreotide-naïve patients with acromegaly...
  38. doi request reprint Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting
    Allison J Hahr
    Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Am J Ther 15:543-50. 2008
    ..The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain...
  39. ncbi request reprint The relationship between glucose control and the development and progression of diabetic nephropathy
    Carrie A Phillips
    Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine of Northwestern University, 303 E Chicago Avenue Tarry 15 731, Chicago, IL 60611, USA
    Curr Diab Rep 2:523-9. 2002
    ....
  40. ncbi request reprint Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline
    Mark E Molitch
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    J Clin Endocrinol Metab 91:1621-34. 2006
    ..The objective is to provide guidelines for the evaluation and treatment of adults with GH deficiency (GHD)...
  41. doi request reprint Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting
    Allison J Hahr
    Division of Endocrinology Metabolism and Molecular Medicine, Northwestern University Feinberg, School of Medicine, Chicago, Illinois
    Dis Mon 56:148-62. 2010
    ..The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain...
  42. pmc Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
    Allan F Moore
    Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    Diabetes 57:2503-10. 2008
    ....
  43. ncbi request reprint Inpatient management of hyperglycemia: the Northwestern experience
    Anthony J DeSantis
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Endocr Pract 12:491-505. 2006
    ..To describe a novel method of safe and effective intensive management of inpatient hyperglycemia with use of cost-effective protocols directed by a glucose management service (GMS)...
  44. pmc The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program
    Mercedes R Carnethon
    Department of Preventive Medicine, Northwestern University, Chicago, Illinois, USA
    Diabetes Care 29:914-9. 2006
    ..2 years...
  45. ncbi request reprint Men with acquired hypogonadotropic hypogonadism treated with testosterone may be fertile
    Andjela Drincic
    Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University, The Feinberg Medical School, Chicago, Illinois 60611, USA
    Pituitary 6:5-10. 2003
    ..This may be related to fact that gonadotropin levels in such patients are present, albeit low. Semen analyses in such men should be routinely carried out so that they can be appropriately counseled regarding potential fertility...
  46. pmc The diabetes prevention program and its global implications
    Mark E Molitch
    Center for Endocrinology, Northwestern University, The Feinberg School of Medicine, Northwestern, Chicago, Illinois, USA
    J Am Soc Nephrol 14:S103-7. 2003
    ....
  47. pmc Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection
    Amisha Wallia
    Division of Endocrinology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Transplantation 89:222-6. 2010
    ..Intensive glycemic control has been shown to positively impact outcomes in an intensive care setting. Whether this practice is beneficial after liver transplantation (LT) is not known...
  48. doi request reprint Insulin resistance following cardiothoracic surgery in patients with and without a preoperative diagnosis of type 2 diabetes during treatment with intravenous insulin therapy for postoperative hyperglycemia
    Patricia Liao
    Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    J Diabetes Complications 22:229-34. 2008
    ..To assess insulin resistance postoperatively in patients with (DM) and without (nonDM) a prior diagnosis of diabetes...
  49. ncbi request reprint Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
    Felipe F Casanueva
    Department of Medicine, Endocrine Division, Santiago de Compostela University, Spain
    Clin Endocrinol (Oxf) 65:265-73. 2006
    ....
  50. ncbi request reprint Nephropathy in diabetes
    Mark E Molitch
    Diabetes Care 27:S79-83. 2004
  51. ncbi request reprint Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease
    Dennis L Andress
    University of Washington School of Medicine, Seattle, Washington, USA
    Endocr Pract 14:18-27. 2008
    ..To review approved treatment options for secondary hyperparathyroidism (SHPT) in patients with stages 3 and 4 chronic kidney disease (CKD)...
  52. ncbi request reprint Diabetic nephropathy
    Mark E Molitch
    Diabetes Care 26:S94-8. 2003
  53. ncbi request reprint Inappropriate prescription for metformin
    Mark E Molitch
    JAMA 288:694; author reply 694-5. 2002
  54. pmc Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus
    Ian H De Boer
    Division of Nephrology, University of Washington, Box 356521, 1959 NE Pacific St, Seattle, WA 98117, USA
    Arch Intern Med 168:1867-73. 2008
    ..Diabetes mellitus and hypertension are closely linked, but the long-term blood pressure effects of glucose-lowering therapy and hyperglycemia are not clear...